12th Biennial Symposium of the International Eosinophil Society, Inc. (IES)

国际嗜酸性粒细胞学会 (IES) 第 12 届双年研讨会

基本信息

批准号：
10682801
负责人：
Steven Jules Ackerman
金额：
$ 0.7万
依托单位：
INTERNATIONAL EOSINOPHIL SOCIETY, INC.
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-03-06 至 2024-02-29
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10682801
关键词：
Academy Address Alberta province Allergic American Animal Disease Models Animal Model Anti-Bacterial Agents Anti-Inflammatory Agents Asthma Autophagocytosis Award Basic Science Belgium Biochemistry Biological Response Modifier Therapy Biology COVID-19 Canada Cell Death Cells Cellular biology Chicago Cities Clinical Clinical Investigator Clinical Research Clinical Treatment Clinical Trials Collaborations Communities Consultations Country Cutaneous Cytoprotection Data Dermatologic Development Diagnostic Diagnostic tests Disease Disseminated eosinophilic collagen disease Educational workshop Ensure Eosinophilic Esophagitis European Faculty Fertilization Fibrosis Fostering Future Generations Goals Health Health Sciences Hematology Homeostasis Host Defense Human Hypersensitivity Immunity Immunobiology Immunology In Vitro Infection Inflammatory Interdisciplinary Study International Leukocytes Malignant Neoplasms Mediating Metabolism Microbiology Mission Molecular Molecular Biology Normal tissue morphology Oral Organ Participant Pathogenesis Pathology Pathway interactions Patients Pharmaceutical Preparations Pharmacology Physiology Play Postdoctoral Fellow Prize Process Public Health Publications Quebec Regulation Research Research Personnel Role Scientist Series Societies Stress Structure Subgroup Sweden Switzerland Therapeutic Translational Research Underrepresented Minority United Kingdom Universities Viral Woman cancer therapy career career development dysbiosis eosinophil gastrointestinal graduate student gut homeostasis human disease improved in vivo injury and repair interest lectures meetings microbiome neoplastic new technology novel novel strategies posters programs research clinical testing response social sound symposium therapeutic target tissue injury trafficking tumor immunology wound healing

项目摘要

CONFERENCE ABSTRACT R13 conference support is requested for the 12th Biennial Eosinophil Symposium, “Eosinophils 2023”, to be held July 11-15, 2023 at the David Braley Health Sciences Centre, McMaster University, Hamilton, ON, Canada under the auspices of the International Eosinophil Society, Inc. (IES). The meeting hosts ~35 invited speakers and ~120 additional participants who submit abstracts. A cutting-edge program of basic, translational and clinical research is being prepared by the IES Scientific Program Committee in consultation with the Local Organizing Committee. Planned sessions include: 1) regulation of eosinophil development and trafficking, 2) eosinophils in tumor immunology and cancer therapy, 3) eosinophils in tissue injury/repair/fibrosis in organ disease, 4) eosinophil regulation of local immunity and interactions with innate and adaptive cells, 5) cell death (and stress, autophagy) in eosinophil biology, 6) reciprocal interactions between eosinophils and microbiomes in gut homeostasis/dysbiosis, 7) eosinophils in GI diseases, 8) eosinophils in host defense; anti-bacterial and viral responses including COVID-19, 9) eosinophils in dermatologic diseases, 10) novel technologies for studying eosinophils in health and disease, and 11) current status and future of eosinophils as therapeutic targets. The overarching goal is to provide a highly interactive, interdisciplinary forum for scientific exchange amongst junior and established scientists in the fields of allergy, immunology, microbiology, hematology, and cancer in relation to the eosinophil’s roles in health and disease. A primary objective is bringing together basic scientists with expertise in eosinophil biology, and clinician investigators interested in eosinophil-associated diseases, to improve understanding of disease mechanisms, significance of eosinophil functions, and foster translational research. A 2nd objective is to foster the development and interests of younger investigators to help support their career development, creating a new generation of “eosinophiles”. The meeting has a Keystone-like-structure with all participants in a single conference venue for unopposed sessions. Both the scientific and social programs emphasize creating a global community for eosinophil scientists. This meeting is particularly timely because new data and approvals of biologic therapies that directly or indirectly block eosinophil-mediated development and inflammatory pathways are now providing definitive findings on the roles of eosinophils in human health and disease. The symposium, with its strong emphasis on inter-disciplinary research, covers important global diseases including asthma, eosinophilic esophagitis, parasitoses, hypereosinophilic syndromes and COVID-19. The format includes plenary and poster sessions, with the former covering state-of-the-art topics by leaders in the field, followed by cutting edge presentations on recent high impact studies, with oral abstract presentations integrated into the sessions. Two unopposed poster sessions include short presentations of high-impact studies. Two prize lectures are included, the Ehrlich Award for a scientist who has made a major overall contribution to the field, and Gleich Award for a scientist with the highest impact publication over the previous two years.

会议摘要为即将举行的第十二届双年度嗜酸性粒细胞研讨会“Eosinophils 2023”请求 R13 会议支持 2023 年 7 月 11 日至 15 日，加拿大安大略省汉密尔顿麦克马斯特大学 David Braley 健康科学中心会议由国际嗜酸性粒细胞协会 (IES) 主办，邀请约 35 名演讲者和嘉宾参加。大约 120 名额外参与者提交了摘要。这是一项基础、转化和临床的前沿项目。 IES 科学计划委员会正在与当地组织协商后准备研究委员会计划的会议包括：1) 嗜酸性粒细胞发育和运输的调节，2) 嗜酸性粒细胞的肿瘤免疫学和癌症治疗，3) 嗜酸性粒细胞在器官疾病中组织损伤/修复/纤维化中的作用，4) 嗜酸性粒细胞调节局部免疫以及与先天和适应性细胞的相互作用，5）细胞死亡（和压力，自噬）在嗜酸性粒细胞生物学中，6）嗜酸性粒细胞和肠道微生物组之间的相互作用稳态/生态失调，7) 胃肠道疾病中的嗜酸性粒细胞，8) 宿主防御中的嗜酸性粒细胞；应对措施，包括 COVID-19、9) 皮肤病中的嗜酸性粒细胞、10) 研究新技术嗜酸性粒细胞在健康和疾病中的作用，11）嗜酸性粒细胞作为治疗靶点的现状和未来。总体目标是为青少年之间的科学交流提供一个高度互动的跨学科论坛并在过敏、免疫学、微生物学、血液学和癌症领域建立了相关科学家嗜酸性粒细胞在健康和疾病中的作用的主要目标是将基础科学家聚集在一起。嗜酸性粒细胞生物学方面的专业知识以及对嗜酸性粒细胞相关疾病感兴趣的临床研究人员，提高对疾病机制、嗜酸性粒细胞功能重要性的理解，并促进转化第二个目标是促进年轻研究人员的发展和兴趣，以帮助支持他们。职业发展，造就新一代“嗜酸细胞” 会议具有类似Keystone的结构。所有参与者都在一个会议场所进行科学和社会项目。强调为嗜酸性粒细胞科学家建立一个全球社区，这次会议特别及时，因为它是新的。直接或间接阻断嗜酸性粒细胞介导的发育的生物疗法的数据和批准炎症途径现在为嗜酸性粒细胞在人类健康和中的作用提供了明确的发现该研讨会非常强调跨学科研究，涵盖了全球重要的疾病。疾病包括哮喘、嗜酸性粒细胞性食管炎、寄生虫病、嗜酸性粒细胞增多综合征和 COVID-19。该形式包括全体会议和海报会议，前者涵盖了各领域领导人的最新主题该领域，随后是关于最近的高影响力研究的前沿演讲，以及口头摘要演讲两个无异议的海报会议包括高影响力研究的简短介绍。其中包括两项获奖演讲：艾利希奖，授予对科学做出重大整体贡献的科学家。格莱希奖（Gleich Award），授予过去两年发表影响力最大的科学家。